Literature DB >> 10648620

Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins.

M Wade1, M J Allday.   

Abstract

Several Epstein-Barr virus (EBV)-negative Burkitt lymphoma-derived cell lines (for example, BL41 and Ramos) are extremely sensitive to genotoxic drugs despite being functionally null for the tumor suppressor p53. They rapidly undergo apoptosis, largely from G(2)/M of the cell cycle. 5-bromo-2'-deoxyuridine labeling experiments showed that although the treated cells can pass through S phase, they are unable to complete cell division, suggesting that a G(2)/M checkpoint is activated. Surprisingly, latent infection of these genotoxin-sensitive cells with EBV protects them from both apoptosis and cell cycle arrest, allowing them to complete the division cycle. However, a comparison with EBV-immortalized B-lymphoblastoid cell lines (which have functional p53) showed that EBV does not block apoptosis per se but rather abrogates the activation of, or signalling from, the checkpoint in G(2)/M. Furthermore, analyses of BL41 and Ramos cells latently infected with P3HR1 mutant virus, which expresses only a subset of the latent viral genes, showed that LMP-1, the main antiapoptotic latent protein encoded by EBV, is not involved in the protection afforded here by viral infection. This conclusion was confirmed by analysis of clones of BL41 stably expressing LMP-1 from a transfected plasmid, which respond like the parental cell line. Although steady-state levels of Bcl-2 and related proteins varied between BL41 lines and clones, they did not change significantly during apoptosis, nor was the level of any of these anti- or proapoptotic proteins predictive of the outcome of treatment. We have demonstrated that a subset of EBV latent gene products can inactivate a cell cycle checkpoint for monitoring the fidelity and timing of cell division and therefore genomic integrity. This is likely to be important in EBV-associated growth transformation of B cells and perhaps tumorigenesis. Furthermore, this study suggests that EBV will be a unique tool for investigating the intimate relationship between cell cycle regulation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648620      PMCID: PMC85280          DOI: 10.1128/MCB.20.4.1344-1360.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  Signal transduction from the Epstein-Barr virus LMP-1 transforming protein.

Authors:  P J Farrell
Journal:  Trends Microbiol       Date:  1998-05       Impact factor: 17.079

Review 2.  Cellular responses to DNA damage.

Authors:  J Y Wang
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

Review 3.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.

Authors:  O Devergne; E D Cahir McFarland; G Mosialos; K M Izumi; C F Ware; E Kieff
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  An information-intensive approach to the molecular pharmacology of cancer.

Authors:  J N Weinstein; T G Myers; P M O'Connor; S H Friend; A J Fornace; K W Kohn; T Fojo; S E Bates; L V Rubinstein; N L Anderson; J K Buolamwini; W W van Osdol; A P Monks; D A Scudiero; E A Sausville; D W Zaharevitz; B Bunow; V N Viswanadhan; G S Johnson; R E Wittes; K D Paull
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

6.  Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.

Authors:  K L Fries; W E Miller; N Raab-Traub
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment.

Authors:  J He; C M Whitacre; L Y Xue; N A Berger; N L Oleinick
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

Review 8.  The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy.

Authors:  A Strasser; D C Huang; D L Vaux
Journal:  Biochim Biophys Acta       Date:  1997-10-24

9.  Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.

Authors:  E Kilger; A Kieser; M Baumann; W Hammerschmidt
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

10.  CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.

Authors:  A G Eliopoulos; C W Dawson; G Mosialos; J E Floettmann; M Rowe; R J Armitage; J Dawson; J M Zapata; D J Kerr; M J Wakelam; J C Reed; E Kieff; L S Young
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

View more
  21 in total

1.  A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.

Authors:  R Touitou; J Richardson; S Bose; M Nakanishi; J Rivett; M J Allday
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

Review 3.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 4.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.

Authors:  G J Inman; U K Binné; G A Parker; P J Farrell; M J Allday
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  At a crossroads: human DNA tumor viruses and the host DNA damage response.

Authors:  Pavel A Nikitin; Micah A Luftig
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

7.  The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.

Authors:  Tathagata Choudhuri; Subhash C Verma; Ke Lan; Masanao Murakami; Erle S Robertson
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

8.  Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53.

Authors:  Jenny O'Nions; Abigail Turner; Richard Craig; Martin J Allday
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

9.  Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.

Authors:  Maria Leao; Emma Anderton; Mark Wade; Kiran Meekings; Martin J Allday
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

10.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.